Gallbladder Stone
Conditions
Keywords
Gallstone, Gallbladder Function, Cholecystitis, Ultrasound Examination
Brief summary
This study is a double-blind, prospective, single-center controlled trial conducted at a tertiary hospital, aiming to determine whether dietary therapy can effectively expel gallstones.
Detailed description
Gallstones are a common clinical condition, and their prevalence has been increasing globally in recent years. Gallstone formation is a result of various combined factors, and in its early stages, gallstones often exist in a sludge-like form. Currently, there is no definitive research on whether gallbladder sludge can be effectively expelled through medication or dietary therapy. Therefore, the investigators are conducting a double-blind, prospective, single-center controlled trial to verify whether gallbladder sludge-like stones can be effectively expelled using dietary therapy.
Interventions
Days 1-3: Oral Administration of functional fatty acids Days 4-6: Oral Administration of functional fatty acids
Days 1-3: Placebo Days 4-6: Oral Administration of functional fatty acids
Sponsors
Study design
Masking description
Double (Investigator, Participant)
Intervention model description
Parallel Assignment
Eligibility
Inclusion criteria
* Gallbladder sludge-like stones with a maximum stone diameter of less than 2 mm
Exclusion criteria
* History of ERCP (Endoscopic Retrograde Cholangiopancreatography) * Previous gallstone removal surgery with gallbladder preservation * History of acute or chronic pancreatitis, cholangitis * Mirizzi Syndrome * History of gastrointestinal surgery * Gastrointestinal obstruction * Dysfunction of the sphincter of Oddi * Gallbladder neck polyps * Abnormal gallbladder structure * Gallbladder mass * Biliary infection or stones * Congenital biliary abnormalities * Biliary injury or surgery * Biliary tumors * Gastrointestinal bleeding, liver cirrhosis, or other malignant diseases * Significant arrhythmia, bradycardia, or atrioventricular block * Severe hypertension, liver or kidney insufficiency * Immune, endocrine, hematological, or mental disorders * Severe cerebrovascular disease * Allergy to relevant foods * Pregnant or breastfeeding women * Unwillingness or inability to consent to participation
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of patients with complete expulsion of gallbladder sludge after three days of intervention | 7 days | Determined by ultrasound examination before and after the intervention to assess whether gallbladder sludge has been fully expelled |
| 2)Number of patients with complete expulsion of gallbladder sludge after six days of intervention | 7 days | Determined by ultrasound examination before and after the intervention to assess whether gallbladder sludge has been fully expelled |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Serum bilirubin | 7 days | Determined by lab examination within 3.4-17.1μmol/L |
| Presence of Abdominal Pain Post-Intervention | 7 days | If abdominal pain is present, it will be assessed using the Numerical Rating Scale (NRS) within 0-10, The higher the score, the more serious it is |
| Gallbladder Volume | 7 days | Measured by ultrasound (L × W × D × 0.52) |
| Occurrence of Gastrointestinal Bleeding Post-Intervention | 14 days | Black stool or decrease of HB |
| Nausea, Vomiting, and Diarrhea Post-Intervention | 14 days | Frequency of Nausea, Vomiting, and Diarrhea Post-Intervention |
| Occurrence of Acute Pancreatitis Post-Intervention | 14 days | Pain and Amy \>3times as normal |
| Gallbladder Wall Thickness | 7 days | Measured by ultrasound, accurate to 0.1 mm |
Countries
China